|
1
|
Basara Akin I and Balci P: Fibroadenomas:
A multidisciplinary review of the variants. Clin Imaging.
71:83–100. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lerwill MF, Lee AHS and Tan PH:
Fibroepithelial tumours of the breast-a review. Virchows Arch.
480:45–63. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Feliciano YZ, Freire R, Net J and Yepes M:
Ductal and lobular carcinoma in situ arising within an enlarging
biopsy proven fibroadenoma. BMJ Case Rep. 14:e2370172021.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Brock CM, Harper C and Tyler T:
Fibroadenoma containing lobular carcinoma in situ, an unusual
finding in a normally benign mass. J Surg Case Rep.
2020:rjaa0592020. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Shojaku H, Hori R, Yoshida T, Matsui K,
Shimada K, Takayanagi N and Noguchi K: Low-grade ductal carcinoma
in situ (DCIS) arising in a fibroadenoma of the breast during 5
years follow-up: A case report. Medicine (Baltimore).
100:e240232021. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Krishnamurthy K, Alghamdi S, Gyapong S,
Kaplan S and Poppiti RJ: A clinicopathological study of
fibroadenomas with epithelial proliferation including lobular
carcinoma in-situ, atypical ductal hyperplasia, DCIS and invasive
carcinoma. Breast Dis. 38:97–101. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fukuda M, Nagao K, Nishimura R, Matsuda M,
Baba K, Ueno Y, Morinaga H, Omachi H and Hamada T: Carcinoma
arising in fibroadenoma of the breast-a case report and review of
the literature. Jpn J Surg. 19:593–596. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wu YT, Wu HK, Chen ST, Chen CJ, Chen DR
and Lai HW: Fibroadenoma progress to ductal carcinoma in situ,
infiltrating ductal carcinoma and lymph node metastasis? Report an
unusual case. J Surg Case Rep. 2017:rjx0642017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Md Nasir ND, Koh VCY, Cree IA, Ruiz BII,
Del Águila J, Armon S, Fox SB, Lakhani SR and Tan PH: Phyllodes
tumour evidence gaps mapped from the 5th edition of the WHO
classification of tumours of the breast. Histopathology.
82:704–712. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yamamoto Y, Hayashi Y, Sakaki H and
Murakami I: Downregulation of fascin induces collective cell
migration in triple-negative breast cancer. Oncol Rep. 50:1502023.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wolff AC, Hammond MEH, Allison KH, Harvey
BE, Mangu PB, Bartlett JMS, Bilous M, Ellis IO, Fitzgibbons P,
Hanna W, et al: Human epidermal growth factor receptor 2 testing in
breast cancer: American society of clinical oncology/college of
American pathologists clinical practice guideline focused update. J
Clin Oncol. 36:2105–2122. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jacobs TW, Gown AM, Yaziji H, Barnes MJ
and Schnitt SJ: Comparison of fluorescence in situ hybridization
and immunohistochemistry for the evaluation of HER-2/neu in Breast
Cancer. J Clin Oncol. 17:1974–1982. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wu YT, Chen ST, Chen CJ, Kuo YL, Tseng LM,
Chen DR, Kuo SJ and Lai HW: Breast cancer arising within
fibroadenoma: Collective analysis of case reports in the literature
and hints on treatment policy. World J Surg Oncol. 12:3352014.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Giuliano AE, Connolly JL, Edge SB,
Mittendorf EA, Rugo HS, Solin LJ, Weaver DL, Winchester DJ and
Hortobagyi GN: Breast Cancer-Major changes in the American Joint
Committee on Cancer eighth edition cancer staging manual. CA Cancer
J Clin. 67:290–303. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Spak DA, Plaxco JS, Santiago L, Dryden MJ
and Dogan BE: BI-RADS ® fifth edition: A summary of
changes. Diagn Interv Imaging. 98:179–190. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shiino S, Yoshida M, Tokura M, Watase C,
Murata T, Jimbo K, Takayama S, Suto A, Satomi K, Miyagi Maeshima A,
et al: Locally advanced triple negative breast cancer arising from
fibroadenoma with complete response to neoadjuvant chemotherapy: A
case report. Int J Surg Case Rep. 68:234–238. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Razakanaivo M, Rakotoarivo T,
Andrianandrasana NO and Rafaramino F: Breast Carcinoma Arising in
Fibroadenoma in a 15-Year-Old Girl; Diagnosis and Treatment
Challenge. J Cancer Ther. 13:615–620. 2022. View Article : Google Scholar
|
|
18
|
Ni XH, An R, Shi QW and Wang CL: Low-Grade
ductal carcinoma in situ within a fibroadenoma of the breast: A
rare case report and review of the literature. Onco Targets Ther.
16:399–406. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Paluch-Shimon S, Cardoso F, Partridge AH,
Abulkhair O, Azim HA, Bianchi-Micheli G, Cardoso MJ, Curigliano G,
Gelmon KA, Gentilini O, et al: ESO-ESMO fifth International
consensus guidelines for breast cancer in young women (BCY5). Ann
Oncol. 33:1097–1118. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ren Y, Li P and Yang Y: Imaging findings
of ductal carcinoma in situ arising within fibroadenoma. Breast J.
26:1037–1038. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tagliati C, Lanni G, Cerimele F, Di
Martino A, Calamita V, Lucidi Pressanti G, Mingliang Y, Giuseppetti
GM, Argalia G and Giovagnoni A: Low diffusion level within a
fibroadenoma as the sole sign of ductal carcinoma in situ: A case
report. Breast Dis. 40:283–286. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Saimura M, Koga K, Anan K, Mitsuyama S and
Tamiya S: Diagnosis, characteristics, and treatment of breast
carcinomas within benign fibroepithelial tumors. Breast Cancer.
25:470–478. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hayes BD and Quinn CM: Microinvasive
lobular carcinoma arising in a fibroadenoma. Int J Surg Pathol.
21:419–421. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Seow DYB, Tay TKY and Tan PH:
Fibroepithelial lesions of the breast: A review of recurring
diagnostic issues. Semin Diagn Pathol. 39:333–343. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Diaz NM, Palmer JO and McDivitt RW:
Carcinoma arising within fibroadenomas of the breast. A
clinicopathologic study of 105 patients. Am J Clin Pathol.
95:614–622. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hammood ZD, Mohammed SH, Abdulla BA, Omar
SS, Naqar S, Salih AM and Kakamad FH: Ductal carcinoma in situ
arising from fibroadenoma; a rare case with review of literature.
Ann Med Surg (Lond). 75:1034492022.PubMed/NCBI
|
|
27
|
Ma XL, Kang L, Li BJ, He CN and Zhao HF:
Invasive ductal carcinoma displayed ‘basal-like’ feature arising
within a breast fibroadenoma. Breast J. 22:695–696. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Fujimoto A, Matsuura K, Kawasaki T,
Ichinose Y, Nukui A, Hiratsuka M, Asano A, Shimada H, Osaki A and
Saeki T: Early HER2-positive breast cancer arising from a
fibroadenoma: A case report. Oxf Med Case Reports.
2021:omab0832021. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Miller-Ocuin JL, Howard-McNatt M, Levine
EA and Chiba A: Is sentinel lymph node biopsy necessary for ductal
carcinoma in situ patients undergoing mastectomy? Am Surg.
86:955–957. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chua BH, Link EK, Kunkler IH, Whelan TJ,
Westenberg AH, Gruber G, Bryant G, Ahern V, Purohit K, Graham PH,
et al: Radiation doses and fractionation schedules in non-low-risk
ductal carcinoma in situ in the breast (BIG 3–07/TROG 07.01): A
randomised, factorial, multicentre, open-label, phase 3 study.
Lancet. 400:431–440. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yang L, Shen M, Qiu Y, Tang T and Bu H:
Molecular subtyping reveals uniqueness of prognosis in breast
ductal carcinoma in situ patients with lumpectomy. Breast. 64:1–6.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wu J, Sun KW, Mo QP, Yang ZR, Chen Y and
Zhong MC: Preoperational diagnosis and management of breast ductal
carcinoma in situ arising within fibroadenoma: Two case reports.
World J Clin Cases. 10:3496–3504. 2022. View Article : Google Scholar : PubMed/NCBI
|
